Catalyst Calendar - March 09, 2026 (EOD)

 ## Today's Catalyst Results How did scheduled events play out? - **Fluent, Inc. (FLNT) Q4 2025 Earnings** - Result: Reported earnings call transcript released; stock declined 1.72% to $3.57 - Market reaction: Negative, reflecting some investor disappointment or cautious sentiment. - **RideNow Group, Inc. (RDNW) Q4 2025 Earnings** - Result: Earnings call transcript released; stock rose 3.40% to $6.70 - Market reaction: Positive, indicating better-than-expected results or outlook. - **Repay Holdings Corporation (RPAY) Q4 2025 Earnings** - Result: Earnings call transcript released; stock fell 3.06% to $2.85 - Market reaction: Negative, suggesting earnings or guidance missed expectations. - **LifeMD, Inc. (LFMD) Q4 2025 Earnings** - Result: Earnings call transcript released; stock surged 8.37% to $3.25 - Market reaction: Strong positive response, likely due to earnings beat or encouraging outlook. - **Acadia Healthcare Company, Inc. (ACHC) Q4 2025 Earnings** - Result: Earnings call transcript released; stock dropped 5.79% to $24.14 - Market reaction: Negative, possibly due to earnings miss or cautious guidance. - **Ascom Holding AG (ACMLF) Q4 2025 Earnings** - Result: Earnings call transcript released; data not available for price reaction. - **3D Systems Corporation (DDD) Q4 2025 Earnings** - Result: Earnings call transcript released; stock surged 28.06% to $2.51 - Market reaction: Very positive, indicating strong earnings or strategic developments. - **Global Business Travel Group, Inc. (GBTG) Q4 2025 Earnings** - Result: Earnings call transcript released; stock up 0.35% to $5.76 - Market reaction: Mildly positive. - **Nayax Ltd. (NYAX) Q4 2025 Earnings** - Result: Earnings call transcript released; stock down 0.39% to $56.03 - Market reaction: Slightly negative. - **Unusual Machines, Inc. (UMAC) Q4 2025 Earnings** - Result: Earnings call transcript released; stock rallied 4.50% to $17.19 - Market reaction: Positive. - **Hewlett Packard Enterprise Company (HPE) 2026 Q1 Earnings** - Result: Earnings call presentation released; stock jumped 4.26% to $22.03 - Market reaction: Strong positive, driven by revenue guidance above estimates and AI-related growth. - **Ionis Pharmaceuticals, Inc. (IONS) Leerink Conference Presentation** - Result: Transcript released; stock rose 1.78% to $75.36 - Market reaction: Positive investor reception. - **Dyne Therapeutics, Inc. (DYN) TD Cowen Conference** - Result: Transcript released; stock surged 17.77% to $17.50 - Market reaction: Very strong, reflecting optimism on clinical data or strategic outlook. - **Vertex Pharmaceuticals (VRTX) Kidney Disease Drug Results** - Result: Positive final-phase results announced; stock soared 6.86% to $488.00 - Market reaction: Strong bullish response on pipeline progress. - **Xenon Pharmaceuticals Inc. (XENE) Phase 3 Seizure Study** - Result: Positive top-line results; stock surged 48.78% to $62.40 - Market reaction: Very strong, signaling breakthrough clinical data. ## Surprise News Today Unexpected developments that moved markets: - **$XENE** - Shares surged 48.78% on positive Phase 3 seizure study results, significantly outperforming peers and signaling potential market-changing drug approval. - **$DDD** - Stock jumped 28.06% following Q4 earnings call, indicating a strong turnaround or new growth drivers. - **$UTHR** - Unusual Machines, Inc. shares jumped 10.95% after earnings call, reflecting renewed investor confidence. - **$LFMD** - LifeMD stock rose 8.37% post-earnings, surprising the market with better-than-expected results. - **$DYN** - Dyne Therapeutics rallied 17.77% on conference presentation, highlighting promising clinical data. - **$HPE** - Hewlett Packard Enterprise gained 4.26% after reporting strong revenue guidance tied to AI trends, exceeding expectations. - **$ALB** - Albemarle surged 4.49%, driven by strong demand in lithium markets amid energy transition themes. - **$AVGO** - Broadcom led AI-related stock gains with a 3.81% increase, reinforcing its leadership in semiconductor growth. - **$MRVL** - Marvell Technology climbed 2.66% on AI-related revenue growth confidence. - **$NVDA** - Nvidia rose 2.01% despite broader market volatility, ahead of GTC event and AI chip anticipation. - **$U** - Unusual Machines surged 6.50%, reflecting strong earnings momentum. - **$MRNA** - Moderna gained 5.86% on positive sentiment around pipeline and biotech sector strength. - **$LYV** - Live Nation jumped 6.19% on legal settlement news, alleviating prior concerns. - **$PWR** - Quanta Services surged 5.16%, likely benefiting from infrastructure spending optimism. - **$GLW** - Corning rallied 5.63% on strong demand in optical networking components. - **$VRTX** - Vertex Pharmaceuticals' 6.86% gain on positive kidney disease drug results. - **$XENE** - Xenon Pharmaceuticals' 48.78% surge on Phase 3 seizure study success. Geopolitical developments also surprised markets: - President Trump announced easing of certain oil-related sanctions on Iran to ensure supply, signaling potential relief in oil markets. - Trump’s comments suggesting the Iran war could end "very soon" triggered a sharp drop in oil prices from earlier spikes, helping equities recover late in the session. - The National Bureau of Economic Research cut ties with Larry Summers, a notable development in economic policy circles. ## After-Hours Catalysts Earnings and events happening tonight: - **$ORCL (Oracle)** - Earnings report expected; investors will watch for AI-related revenue growth and guidance amid high expectations. - **$ULTA (Ulta Beauty)** - Earnings due; focus on consumer spending trends and margin outlook. - **$ADBE (Adobe)** - Earnings release; market will assess AI integration progress and subscription growth. - **$DG (Dollar General)** - Earnings report; watch for consumer demand signals in discount retail. - **$DKS (Dick’s Sporting Goods)** - Earnings; key for discretionary spending trends. - **$AVAV (AeroVironment)** - Earnings; defense sector growth and order backlog updates. - **$BMBL (Bumble)** - Earnings; user growth and monetization metrics. - **$BNTX (BioNTech)** - Earnings; pipeline updates and COVID-19 vaccine demand. - **$CASY (Casey’s General Stores)** - Earnings; fuel margin impact amid oil price volatility. - **$CPB (Campbell Soup)** - Earnings; consumer staples resilience. - **$SERV (ServiceNow)** - Earnings; cloud software growth. - **$SRFM (Seres Therapeutics)** - Earnings; biotech pipeline progress. - **$UEC (Uranium Energy Corp)** - Earnings; uranium market dynamics. - **$VOYG (Voyager Digital)** - Earnings; crypto market exposure. - **$WPM (Wheaton Precious Metals)** - Earnings; precious metals demand. ## Tomorrow's Calendar Key events scheduled for tomorrow: - **G7 Energy Ministers Meeting** - Time: Tuesday morning - Watch for: Potential joint release of emergency oil reserves to stabilize surging oil prices amid Middle East conflict. - **$ORCL Earnings** - Time: After market close - Watch for: AI revenue growth, cloud business performance, and guidance amid high market expectations. - **$ULTA Earnings** - Time: After market close - Watch for: Consumer spending trends and margin outlook. - **$ADBE Earnings** - Time: After market close - Watch for: AI product integration and subscription growth metrics. - **$DG Earnings** - Time: After market close - Watch for: Retail demand in discount sector. - **$DKS Earnings** - Time: After market close - Watch for: Discretionary consumer spending signals. - **$AVAV Earnings** - Time: After market close - Watch for: Defense order book and growth prospects. ## This Week Ahead Other catalysts coming this week: - Tuesday: G7 meeting on oil reserves release amid ongoing Middle East tensions. - Later this week: Multiple earnings from major tech and retail companies, including Oracle, Ulta, Adobe, and others, which will provide further clarity on AI adoption and consumer trends. ## Highest Conviction Setup Based on today's action and upcoming catalysts: - Stock: **$XENE (Xenon Pharmaceuticals)** - Catalyst: Positive Phase 3 clinical trial results for seizure drug and strong investor response. - Thesis: The significant 48.78% surge reflects market recognition of a potential breakthrough therapy with substantial commercial upside. Upcoming analyst coverage upgrades and potential partnerships could further drive momentum. The biotech sector's current focus on innovative treatments supports a favorable risk/reward profile. Additional high conviction names include **$DDD** for its strong earnings rebound and **$HPE** for its AI-driven revenue guidance, both poised to benefit from secular growth trends and positive market sentiment.